Oncogenic Role of SATB2 In Vitro: Regulator of Pluripotency, Self-Renewal, and Epithelial–Mesenchymal Transition in Prostate Cancer
Cells · 2024
DOI: 10.3390/cells13110962 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Wei Yu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Kansas City VA Medical Center, 4801 Linwood Boulevard, Kansas City, MO 66128, USA. Hauptthemen laut MEDLINE: Epithelial-Mesenchymal Transition, Prostatic Neoplasms, Kruppel-Like Factor 4, Matrix Attachment Region Binding Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Special AT-rich sequence binding protein-2 (SATB2) is a nuclear matrix protein that binds to nuclear attachment regions and is involved in chromatin remodeling and transcription regulation. In stem cells, it regulates the expression of genes required for maintaining pluripotency and self-renewal and epithelial–mesenchymal transition (EMT). In this study, we examined the oncogenic role of SATB2 in prostate cancer and assessed whether overexpression of SATB2 in human normal prostate epithelial cells (PrECs) induces properties of cancer stem cells (CSCs). The results demonstrate that SATB2 is highly expressed in prostate cancer cell lines and CSCs, but not in PrECs. Overexpression of SATB2 in PrECs induces cellular transformation which was evident by the formation of colonies in soft agar and spheroids in suspension. Overexpression of SATB2 in PrECs also resulted in induction of stem cell markers (CD44 and CD133), pluripotency-maintaining transcription factors (cMYC, OCT4, SOX2, KLF4, and NANOG), CADHERIN switch, and EMT-related transcription factors. Chromatin immunoprecipitation assay demonstrated that SATB2 can directly bind to promoters of BCL-2, BSP, NANOG, MYC, XIAP, KLF4, and HOXA2, suggesting SATB2 is capable of directly regulating pluripotency/self-renewal, cell survival, and proliferation. Since prostate CSCs play a crucial role in cancer initiation, progression, and metastasis, we also examined the effects of SATB2 knockdown on stemness. SATB2 knockdown in prostate CSCs inhibited spheroid formation, cell viability, colony formation, cell motility, migration, and invasion compared to their scrambled control groups. SATB2 knockdown in CSCs also upregulated the expression of E-CADHERIN and inhibited the expression of N-CADHERIN, SNAIL, SLUG, and ZEB1. The expression of SATB2 was significantly higher in prostate adenocarcinoma compared to normal tissues. Overall, our data suggest that SATB2 acts as an oncogenic factor where it is capable of inducing malignant changes in PrECs by inducing CSC characteristics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Kansas City VA Medical Center, 4801 Linwood Boulevard, Kansas City, MO 66128, USA.
- Department of Chemistry and Biochemistry, Baylor University, Waco, TX 76798, USA.
- Louisiana State University, Baton Rouge, LA 70803, USA.
- John W. Deming Department of Medicine, Tulane University School of Medicine, New Orleans, LA 70112, USA.
- Southeast Louisiana Veterans Health Care System, 2400 Canal Street, New Orleans, LA 70119, USA.
- GLAX LLC, 3500 S Dupont Highway, Dover, DE 19901, USA.
ORCID-Profile: Yiming Ma
Zitieren
APA
Yu, W., Srivastava, R., Srivastava, S., Ma, Y., Shankar, S., & Srivastava, R. K. (2024). Oncogenic Role of SATB2 In Vitro: Regulator of Pluripotency, Self-Renewal, and Epithelial–Mesenchymal Transition in Prostate Cancer. Cells. https://doi.org/10.3390/cells13110962
Vancouver
Yu W, Srivastava R, Srivastava S, Ma Y, Shankar S, Srivastava RK. Oncogenic Role of SATB2 In Vitro: Regulator of Pluripotency, Self-Renewal, and Epithelial–Mesenchymal Transition in Prostate Cancer. Cells. 2024. doi:10.3390/cells13110962
BibTeX
@article{Yu2024,
author = {Yu, Wei and Srivastava, Rashmi and Srivastava, Shivam and Ma, Yiming and Shankar, Sharmila and Srivastava, Rakesh K},
title = {Oncogenic Role of SATB2 In Vitro: Regulator of Pluripotency, Self-Renewal, and Epithelial–Mesenchymal Transition in Prostate Cancer},
journal = {Cells},
year = {2024},
doi = {10.3390/cells13110962}
}
EUVIMED